| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.36 | 0.08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.35 | 0.08 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.08 |